(Q34625671)

3 August 2017

title

Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases (English)

1 reference

3 August 2017

Liyuan Tian

1

1 reference

3 August 2017

Yu Wang

2

1 reference

3 August 2017

Dabin Xu

3

1 reference

3 August 2017

Junhao Gui

4

1 reference

3 August 2017

Xingwang Jia

5

1 reference

3 August 2017

Hongli Tong

6

1 reference

3 August 2017

Xinyu Wen

7

1 reference

3 August 2017

Zhennan Dong

8

1 reference

3 August 2017

Yaping Tian

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

11 March 2011

1 reference

International Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

129

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

1923-1931

1 reference

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

3 August 2017

cites work

1 reference

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

International trends and patterns of primary liver cancer.

21 January 2018

1 reference

N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing

21 January 2018

1 reference

N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma

21 January 2018

1 reference

GP73, a novel Golgi-localized protein upregulated by viral infection

21 January 2018

1 reference

Disease- and cell-specific expression of GP73 in human liver disease

21 January 2018

1 reference

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.

21 January 2018

1 reference

Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease

21 January 2018

1 reference

GP73 and liver disease: a (Golgi) complex enigma

21 January 2018

1 reference

GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population

21 January 2018

1 reference

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

21 January 2018

1 reference

Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers

21 January 2018

1 reference

Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases

21 January 2018

1 reference

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma: diagnosis and treatment

21 January 2018

1 reference

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

Risk factors for primary liver carcinoma in Chinese population

21 January 2018

1 reference

Chronic hepatitis B virus infection in Asian countries

21 January 2018

1 reference

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

21 January 2018

1 reference

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

Co-expression of the proprotein-processing endoprotease furin and its substrate transforming growth factor beta1 and the differentiation of rat hepatocytes.

21 January 2018

1 reference

Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma

21 January 2018

1 reference

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25838

1 reference

3 August 2017

1 reference